Clinical Trial Update: Medication Development for Opioid and Alcohol Abuse [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results for a medication targeting opioid-use disorder and alcohol use disorder have been completed, with results posted in October 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Opioid Use Disorder

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Opioid-use Disorder, Alcohol Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2022-10-06